Federal Register / Vol. 76, No. 50 / Tuesday, March 15, 2011 / Notices 14035 

Type of Information Collection Request: 

Existing Collection in Use Without an 

OMB Number. Need and Use of 

Information Collection: The purpose of 

the online application form and the 

Web-based update mailer is to collect 

information about genetics professionals 

to be included in the NCI Cancer 

Genetics Services Directory on NCI’s 

Cancer.gov Web site. The information 

collected includes name, practice 

locations, professional qualifications, 

and areas of specialization. Frequency of 

Response: Information is collected once 

via the online application form, and 

then updated annually via the Webbased mailer. Affected Public: 

Individuals. Type of Respondents: 

Genetics professionals including nurses, 

physicians, genetic counselors, and 

other professionals who provide 

services related to cancer genetics. The 

annual reporting burden is estimated at 

180 hours (see Table below). There are 

no Capital Costs, Operating Costs, and/ 

or Maintenance Costs to report. 

TABLE 1—ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Tool Number of 

respondents 

Frequency of 

response 

Average time 

per response 

minutes/hour 

(hours) 

Annual burden 

hours 

Genetics Professionals ........................... Application Form ......................... 60 1 30/60 

(.50) 

30 

Web-based Update Mailer .......... 600 1 15/60 

(0.25) 

150 

Totals ............................................... ..................................................... 660 ........................ ........................ 180 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

For Further Information Contact: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Margaret Beckwith, 

Acting Branch Chief, International 

Cancer Research Databank Branch, 

Office of Cancer Content Management, 

Office of Communication and 

Education, National Cancer Institute, 

6116 Executive Blvd., Rockville, MD 

20852, or call non-toll-free number 301– 

496–9096 or e-mail your request, 

including your address to: 

mbeckwit@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: March 9, 2011. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2011–6021 Filed 3–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Establishment 

Pursuant to the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

app.), the Director, National Institutes of 

Health (NIH), announces the 

establishment of the NCI-Frederick 

Advisory Committee. 

The Council will provide advice and 

recommendations to the Director, 

National Cancer Institute (NCI), and the 

Associate Director, NCI-Frederick, on 

the optimal use of the NCI-Frederick 

facility to rapidly meet the most urgent 

needs of the NCI. The Committee will 

consist of 16 members, including the 

Chair, appointed by the Director, NCI. 

Members will be authorities 

knowledgeable in drug and vaccine 

development, clinical trials support, 

AIDS research, bioinformatics, 

genomics, nanotechnology, biological 

repositories, and basic research in 

immunology and infectious diseases. 

Duration of this committee is 

continuing unless formally determined 

by the Director, NCI that termination 

would be in the best interest of the 

public. 

Dated: March 9, 2011. 

Francis S. Collins, 

Director, National Institutes of Health. 

[FR Doc. 2011–6023 Filed 3–14–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; Career 

Development, Research Training and 

Pathways to Independence Grant Review. 

Date: March 29, 2011. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 


srobinson on DSKHWCL6B1PROD with NOTICES